Marché du cannabidiol (CBD) en Amérique du Nord – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché du cannabidiol (CBD) en Amérique du Nord

Le marché nord-américain du cannabidiol (CBD) devrait connaître une croissance du marché au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse que le marché croît avec un TCAC de 28,7 % au cours de la période de prévision de 2022 à 2029. Les avancées technologiques dans les traitements médicamenteux au cannabidiol (CBD), l'essor du secteur de la santé sont d'autres facteurs qui stimulent la croissance du marché nord-américain du cannabidiol (CBD) au cours de la période de prévision.

Cependant, les effets secondaires associés à l'huile de CBD et aux produits contrefaits et synthétiques disponibles sur le marché freineront la croissance du marché. L'adoption d'alliances stratégiques telles que les partenariats et les acquisitions par des acteurs clés du marché constitue une opportunité pour la croissance du marché nord-américain du cannabidiol (CBD).

Définition du marché du cannabidiol (CBD)

Cannabidiol (CBD) is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content. It has several benefits in treating anxiety and seizures and reducing pain. Due to its healing properties, the demand for CBD for health and wellness purposes is high, which is the major factor driving the market. Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the North America market is anticipated to grow at a lucrative rate over the forecast period. Cannabidiol oil is increasingly being used to make skincare products to treat acne and wrinkles. Sephora, for example, had recently introduced cannabidiol or CBD skincare line to its stores. Similarly, Ulta Beauty is intending to launch a cannabidiol-based product line. Several new companies are also entering the market for cannabidiol-infused cosmetic products.

Furthermore, the government of different countries as well as major players in the cannabinoid market are investing in research and development activities. The CBD is said to be an effective treatment for various neurological diseases including epilepsy in several clinical trials.

Market Dynamics                                        

Drivers

• Increasing demand for CBD in health & fitness

Rising awareness among consumers regarding health and fitness will help CBD market to witness rapid growth. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in this sector.

Moreover, CBD products are used to relieve various problems such as anxiety/ stress, sleep/insomnia, chronic pain, migraine, skin care, seizures, joint pain & inflammation, neurological conditions, and many others. The chronic pain treatment has gained much popularity due to additional benefits offered by CBD when used. There has been increasing demand for cannabidiol (CBD) products over recent years owing to its widespread medical applications and pain relief treatment. CBD helps in reducing chronic pain by acting on variety of biological process in the body. In addition, CBD possesses antioxidant, anti-inflammatory and analgesic properties. Therefore, CBD products reduces the anxiety that is experienced by the people suffering from the chronic pain. Thus, the increasing demand for CBD in the treatment of chronic pain is augmenting the market to grow. This also help people to maintain their health and fitness routines, while staying away from pain that may occur during fitness activities.

• Improving government approvals and regulations for CBD products

There are strict government regulations and CBD based products required strict approvals before they were marketed and supplied in the local as well international market, which limited the growth of the market. However, with time these restrictions have been eased up and there has been increasing acceptance of refined CBD products combined with the increasing legalization of marijuana and marijuana-derived products for various applications. This will drive the growth and demand in the market.

Moreover, there is the presence of major manufacturers of CBD products across the globe which has further induced the government and other regulatory bodies such as Food and Drug Administration (F.D.A.) in the U.S., European Union in Europe, etc. to ease up the restrictions for CBD and CBD based products.

Restraint

• High cost of CBD products

CBD is a popular and a holistic choice for people struggling with pain, inflammation, and sleep problems. Since CBD is a new product with less research and development and has lately been regulated and approved, therefore, the price of CBD are subject to fluctuations. The production of hemp became legal in 2018, which affected the price of CBD products. As a result, various CBD products witnessed some price inflation.

Moreover, many farmers are transitioning towards growing and selling hemp used to make CBD products, but despite the increased popularity of this product, it presents its own agricultural challenges. Firstly, switching over to a new crop results in new expenses. The most efficient way to harvest hemp is using a combine harvester. However, farmers who have previously grown crops that don’t require combines, such as strawberries, can’t afford to purchase a combine right away. Therefore, they need to hire people to help harvest the hemp, which drives up overall product prices as the raw material becomes costly.

Additionally, hemp requires more time and labor to grow and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD need to use either ethanol or supercritical carbon dioxide (CO2 extraction). The extraction and refinement process requires special machinery and takes a long time, which drives up the CBD cost. Thus, all these factors add up to the costs of CBD products making them much more costly than other products, which is likely to restrain the market’s demand.

Opportunity

• Increasing investments in development of new CBD based products

With the increasing trend of providing innovative and refined products in the market, manufacturers are spending large amounts in research and development for the production of new CBD based products. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand.

The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products in turn providing opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.

Moreover, with the ease in regulations and post the approval of cannabis products, the companies are investing huge amounts in the product development and upgrading the raw material production, which will also help them to cut down on costs while meeting the surging demand in the market. The new product development and increasing research and development activities along with various strategic decisions taken by key manufacturers in the market will offer lucrative opportunity for the growth of the North America CBD market.

Challenge

• Side effects associated with CBD oil

Cannabidiol is well-known for its ability to cure a variety of illnesses, including anxiety, seizures, neurological problems, cancer-related nausea, chronic pain, and more. However, being useful for a variety of medical illnesses, various studies and research conducted by numerous organizations have shown that CBD-based medicines can have negative effects as well.

Some of the side effects that are commonly experienced by consumers include dry mouth, drowsiness, low blood pressure, and lightheadedness. CBD is also known to raise the level of Coumadin (a blood thinner) in the body, which can interact with other drugs and cause negative side effects. These factors might impede future adoption of CBD for therapeutic purposes.

Moreover, another cause for concern is the unreliability of the purity and dosage of CBD in products such as CBD oil. High concentration of CBD oil can also have harmful effects on the consumers’ health. In some cases, excessive use of CBD oil may also increase liver enzymes, which is a marker of liver inflammation. Cytochrome P450 (CYP450) is an enzyme which body uses to break down some drugs. CBD oil can block CYP450. That means that taking CBD oil with these drugs could make them have a stronger effect than one needs or make them not work at all.

Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may pose as a challenge for the increasing demand of CBD products in the North America CBD market.

Post COVID-19 Impact on North America cannabidiol (CBD) market

La COVID-19 a entraîné une augmentation substantielle de la demande de fournitures médicales, tant de la part des professionnels de la santé que du grand public, pour des raisons de précaution. Les fabricants de ces articles ont la possibilité de profiter de la demande accrue de fournitures médicales en garantissant un approvisionnement constant d'équipements de protection individuelle sur le marché. La COVID-19 devrait avoir un impact important sur le marché nord-américain du cannabidiol (CBD).

Portée et taille du marché du cannabidiol (CBD) en Amérique du Nord

Le marché nord-américain du cannabidiol (CBD) est segmenté en fonction de la source, de la qualité, de l'application, du type de produit et de la nature. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.

PAR SOURCE

• CHANVRE
• MARIJUANA

Sur la base de la source, le marché nord-américain du cannabidiol (CBD) est segmenté en chanvre et en marijuana.

PAR TYPE DE PRODUIT

• HUILE DE CBD
• ISOLATS DE CBD
• CONCENTRÉS DE CBD
• AUTRES

Sur la base du type de produit, le marché nord-américain du cannabidiol (CBD) est segmenté en huile de CBD, concentrés de CBD, isolats de CBD et autres

PAR NATURE

• ORGANIQUE
• INORGANIQUE

Sur la base de la nature, le marché nord-américain du cannabidiol (CBD) est segmenté en organique et inorganique.

PAR GRADE

• QUALITÉ ALIMENTAIRE
• QUALITÉ THÉRAPEUTIQUE

Sur la base de la qualité, le marché nord-américain du cannabidiol (CBD) est segmenté en qualité alimentaire et qualité thérapeutique.

SUR DEMANDE

• Teinture
•  Nourriture
•  Boissons
• Pharmaceutique
• Sujets d'actualité
• Compléments alimentaires
• Autres

Sur la base de l'application, le marché nord-américain du cannabidiol (CBD) est segmenté en teinture, aliments, boissons, produits pharmaceutiques, produits topiques, compléments alimentaires et autres.

Analyse du marché du cannabidiol (CBD) en Amérique du Nord au niveau des pays

Le marché du cannabidiol (CBD) est analysé et des informations sur la taille du marché sont fournies par source, qualité, application, type de produit et nature.

Les pays couverts par le rapport sur le marché du cannabidiol (CBD) sont les États-Unis, le Canada et le Mexique.

En 2022, les États-Unis dominent le marché grâce à la présence d'acteurs clés sur le plus grand marché de consommation avec un PIB élevé. Les États-Unis devraient connaître une croissance en raison de l'augmentation des progrès technologiques dans les traitements médicamenteux.

La section du rapport sur les pays fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, les actes réglementaires et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario du marché pour les différents pays. En outre, la présence et la disponibilité des marques nord-américaines et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Le marché du cannabidiol (CBD) vous fournit également une analyse de marché détaillée pour chaque pays en termes de croissance du secteur de la santé. De plus, il fournit des informations détaillées sur les services et traitements de santé, l'impact des scénarios réglementaires et les paramètres de tendance concernant le marché du cannabidiol (CBD).

Analyse du paysage concurrentiel et des parts de marché du cannabidiol (CBD) en Amérique du Nord

Le paysage concurrentiel du marché du cannabidiol (CBD) en Amérique du Nord fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives de marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'ampleur du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers les produits à base de cannabidiol (CBD).

Français Les principales entreprises qui s'occupent du marché du cannabidiol (CBD) sont CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE'S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads entre autres.

Les alliances stratégiques telles que les fusions, les acquisitions et les accords entre les principaux acteurs du marché devraient encore accélérer la croissance des produits à base de cannabidiol (CBD).

Par exemple,

• En mai 2022, Canopy Growth Corporation et Lemurian, Inc., un producteur californien d'extraits de cannabis de haute qualité et pionnier de la technologie de vapotage propre, ont annoncé avoir conclu des accords définitifs accordant à Canopy Growth, par l'intermédiaire d'une filiale à 100 %, le droit d'acquérir, dès l'autorisation fédérale du THC aux États-Unis ou plus tôt au choix de Canopy Growth, jusqu'à 100 % du capital social en circulation de Jetty. Cela a aidé l'entreprise à développer ses activités sur le marché.

SKU-68910